Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples